Interleukin 10 and lnterleukin 13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis

Nephron

Volumn 77, Issue 2, 1997, Pages 212-218

  Matsumoto, Koichi ^a   Ohi, Hiroyuki ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgA nephropathy; Interleukin 10; Interleukin 13; Lipoid nephrosis; Vascular permeability factor

Indexed keywords

CONCANAVALIN A; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; LIPOID NEPHROSIS; MACROPHAGE; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DEPRESSION, CHEMICAL; DRUG SYNERGISM; ENDOTHELIAL GROWTH FACTORS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; LYMPHOKINES; MALE; MIDDLE AGED; MONOCYTES; NEPHROSIS, LIPOID; NEUTRALIZATION TESTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030760543     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190275     Document Type: Article

References (13)

1. Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B: Vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome, Biomedicine 1975;23:37-40.
2. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interlcukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of 1L-10 produced by monocytes. J Exp Med 1991; 174; 1209-1220.
3. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytokine function of human monocytes: Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993;156:6370-6381.
4. Sobel AT, Branellec AI, Blanc CJ, Lagrue GA: Physicochemical characterization of a vascular permeability factor produced by ConA-stimu-lated human lymphocytes. J Immunol 1977: 119:1230-1234.
5. Ovary Z: A new method for quantitative determination of anaphylactic antibody in sera of guinea pigs and rabbits. Proc Int Congr Allergy 1951:156:315.
6. Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC: Dexamethasone inhibition of interleukin-1 beta production by human monocytes. J Clin Invest 1988;81:237-244.
7. Matsumoto K: Spontaneous and lipopolysac-charide-stimulated secretion of cytokines by peripheral blood monocytes in IgA nephropathy is inhibited by interlcukin-10. Nephron 1996:73:305-309.
8. Matsumoto K: Interleukin-13 inhibits cytokine secretion by blood monocytes from patients with IgA nephropathy. Nephron 1997;75:295-302.
9. D’Andrea A, Aste-Amczaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 (IL-10) inhibits human lymphocyte intcrferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993:178:1041-1048.
10. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type I and cytotoxic lymphocytes. Blood 1994;84:4008-4027.
11. Heslan J-MJ, Branellec A, Pilatte Y, Lang P, Lagrue G: Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimalchange nephrotic syndrome, Clin Exp Immunol 1991;86:157-162.
12. Fiorcntino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J Immunol 1991:146:3444-3451.
13. Li L, Elliott JF, Mosmann TR: IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1-cell-induccd delayed-type hypersensitivity. J Immunol 1994: 153:3967-3978.